← Journal search
JOURNAL PROFILE
Download details (PDF) ↓

Neuropsychiatric Disease and Treatment (ISSN 1178-2021) is an open-access journal published by Taylor & Francis in the United Kingdom. It covers Medicine, Neuroscience, Psychiatry and Mental Health and Biological Psychiatry. It is indexed in Scopus, Web of Science, PubMed, DOAJ and HEC. Recorded metrics: impact factor 3.2, Scopus Q2, Web of Science Q2, CiteScore 5.3 and HEC W-Category. Article processing charge: USD 3,940. This profile brings together the journal's ISSN, publisher, country, subject area, HEC category, Scopus data, SJR and SCImago rank, Web of Science data, impact factor, indexing, open access status, APC, waiver policy, time to publication, aims and scope, about the journal, author instructions, journal website and registration details from the most reputable indexes, in one place.

Journal title

Neuropsychiatric Disease and Treatment

ISSN
1178-2021
Subject area
MedicineNeurosciencePsychiatry and Mental HealthBiological Psychiatry
Indexed
ScopusWeb of SciencePubMedDOAJHEC
Scopus Quartile
Q2
WoS Quartile
Q2
Impact Factor
3.2
Country
United Kingdom
Publisher
Taylor & Francis
SJR
0.947
Open access
Yes
APC (USD)
3940
About the journal
Neuropsychiatric Disease and Treatment is a fully open-access journal published by Dove Medical Press (United Kingdom). It has published all content under an open licence (CC BY, CC BY-NC) since 2009. Topics: neuropsychiatric disorders, neurological disorders, clinical neurology, clinical neuropsychiatry.
Aims and Scope
The journal publishes research on the clinical and biological dimensions of neuropsychiatric and neurological disorders, including studies of pharmacology, treatment strategies, diagnosis, prognosis, epidemiology, and genetic associations. Its coverage includes conditions such as autism spectrum disorder, ADHD, anxiety and mood disorders, schizophrenia, dementia, Parkinson’s disease, epilepsy, multiple sclerosis, migraine, and neuropsychiatric effects of stroke; it also considers research on the normal brain that may illuminate disease or treatment mechanisms. The journal welcomes original research, reviews and evaluations, guidelines, expert opinion, commentary, and extended reports; case reports and case series are redirected to a section of the International Medical Case Reports Journal.
SCImago Ranking
5342
HEC
W-Category
Journal Website
www.dovepress.com/neuropsychiatric-disease-and-treatment-journal ↗
Registered In
2009
Instructions for Authors URL
www.dovepress.com/author_guidelines.php ↗
Average Time To Publication After Submission (In Weeks)
16
APC Information URL
www.dovepress.com/journal_pricing_bands.php?journal_id=3 ↗
Waiver policy
Yes
Scopus URL
www.scopus.com/sourceid/4100151703 ↗
Scopus Cite Score
5.3
WoS Status
Science Citation Index Expanded (SCIE)

Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.

Quick answers about Neuropsychiatric Disease and Treatment

Is Neuropsychiatric Disease and Treatment HEC recognised?

Yes. The catalogue records Neuropsychiatric Disease and Treatment in HEC category W of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.

Is Neuropsychiatric Disease and Treatment indexed in Scopus?

Yes. Neuropsychiatric Disease and Treatment is listed as Scopus-indexed, in quartile Q2, with a CiteScore of 5.3. Check its current status on the Scopus Sources page.

Is Neuropsychiatric Disease and Treatment in Web of Science?

Yes. Neuropsychiatric Disease and Treatment is listed as a Web of Science journal in the Science Citation Index Expanded (SCIE), with Web of Science quartile Q2. Confirm on Clarivate's Master Journal List.

What is the impact factor of Neuropsychiatric Disease and Treatment?

The recorded journal impact factor of Neuropsychiatric Disease and Treatment is 3.2. Clarivate updates impact factors every year in Journal Citation Reports.

Is Neuropsychiatric Disease and Treatment open access, and what does it charge?

Neuropsychiatric Disease and Treatment is an open-access journal and its APC is USD 3,940. Fees change, so check the journal's website before you submit.

How long does Neuropsychiatric Disease and Treatment take to publish?

The recorded average time from submission to publication is about 16 weeks. Individual papers can take longer, especially when revisions are requested.

Who publishes Neuropsychiatric Disease and Treatment?

Neuropsychiatric Disease and Treatment is published by Taylor & Francis in United Kingdom, under ISSN 1178-2021.

Research profile

Main research topics: Schizophrenia research and treatment, Treatment of Major Depression, Dementia and Cognitive Impairment Research, Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes, Bipolar Disorder and Treatment, Mental Health Treatment and Access.

Source: OpenAlex (CC0), retrieved 21 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.

Browse similar journals

Find Journal